id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
work_zgpxbhnmbfbhjnc3icagpj3vfu	Amish A. Patel	Effects of eicosapentaenoic acid and docosahexaenoic acid on lipoproteins in hypertriglyceridemia	2016.0	6	.pdf	application/pdf	4038	411	62	The treatment of hypertriglyceridemia (HTG) with v-3 fatty acid preparations adds a novel therapy to The evidence that v-3 fatty acid therapy at prescription strength is effective and safe at lowering Although EPA/docosahexaenoic acid formulations did lower triglyceride trials have shown that decreased levels of low-density lipoprotein can be achieved with EPA preparations. The addition of v-3 fatty acid treatment should be considered in patients with severe HTG as well as Major clinical factors of CVD risk include highplasma cholesterol and high triglycerides. interventions to lower triglyceride levels include statins, fibrates, nicotinic acid, and v-3 fatty acids [13,21]. " v-3 fatty acid consistently lowers triglyceride levels. " v-3 fatty acids add a novel therapy to at risk patients. icosapent ethyl 2 g/day decreased triglyceride levels DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; HTG, hypertriglyceridemia; LDL, low-density lipoprotein; TG, triglyceride. patients with very high triglyceride levels (the MARINE study).	./cache/work_zgpxbhnmbfbhjnc3icagpj3vfu.pdf	./txt/work_zgpxbhnmbfbhjnc3icagpj3vfu.txt